Research article |

PLoS: Randomized Trials to Optimize Treatment of Multidrug-Resistant Tuberculosis

Authors: Carole D. Mitnick, Kenneth G. Castro, Mark Harrington, Leonard V. Sacks and William Burman

For the first time in 30 years, several new drug classes that hold promise for MDR-TB treatment are under development; these new agents should be evaluated in parallel for drug-resistant and drug-susceptible TB.